Overview
INJ and AKT rarely move in perfect sync. Today’s print ($5.04/$1,857.63) and 24h leaders (AKT) help frame which side currently carries relative strength.
Quick winners
Full comparison
| Metric | INJ | AKT |
|---|---|---|
| Price | $5.04 | $1,857.63 |
| Market Cap | $490.41M | $142.80M |
| FDV | — | — |
| Volume 24h | $3.19M | $4.12M |
| Circulating Supply | — | — |
| Total Supply | — | — |
| Max Supply | — | — |
| Rank | 100.00 | 202.00 |
| Dominance | — | — |
| Liquidity | — | — |
| Volatility | +5.78% | +3.50% |
| ATH | — | — |
| ATL | — | — |
| ROI | — | — |
Performance
| Timeframe | INJ | AKT |
|---|---|---|
| 1H | — | — |
| 24H | +1.47% | +2.20% |
| 7D | — | — |
| 30D | — | — |
| 90D | — | — |
| 1Y | — | — |
| YTD | — | — |
| ALL | — | — |
Comparative chart
Technical indicators
| Indicator | INJ | AKT |
|---|---|---|
| RSI | 53.92 | 54.31 |
| MACD histogram | — | — |
| EMA20 | — | — |
| EMA50 | — | — |
| EMA100 | — | — |
| EMA200 | — | — |
| SMA50 | — | — |
| SMA200 | — | — |
| ATR | 0.29 | 66.45 |
| ADX | 12.69 | 20.44 |
| Support | 4.91 | 1,827.82 |
| Resistance | 5.47 | 1,960.30 |
| Trend | neutral | bearish |
| Momentum | — | 63.00 |
| Signal | neutral | neutral |
Automatic technical analysis
Technically, Injective shows RSI 53.92 with trend bias neutral, while AKT sits at RSI 54.31 (bearish). Divergences between momentum and price should be confirmed on higher timeframes.
Fundamentals
| Metric | INJ | AKT |
|---|---|---|
| Consensus | — | — |
| Blockchain | — | — |
| TPS | — | — |
| Block time | — | — |
| Finality | — | — |
| Validators | — | — |
| Staking | — | — |
| TVL | — | — |
| Supply model | — | — |
| Inflation | — | — |
| Developer activity | 0.00 | — |
| Github activity | 118.00 | — |
| On-chain activity | — | — |
| Whale activity | — | — |
| Addresses | — | — |
| Gas fees | — | — |
Ecosystem
Injective
AKT
Pros and cons
Pros of Injective
- Injective typically benefits from deeper liquidity and broader market recognition inside the Top 300 set.
- Market-cap scale on Injective may dampen some idiosyncratic shocks versus smaller peers.
- Injective has an established coin page footprint on PEPS for continuous monitoring.
- INJ often anchors narratives that attract sustained media and analyst coverage.
Cons of Injective
- Data gaps in niche fundamentals still apply — absence of a field is not confirmation.
- When dominance narratives fade, Injective can lag hotter rotation names.
- Crowded positioning around INJ sometimes amplifies squeeze or flush risk.
Pros of AKT
- If technical momentum aligns, AKT may outperform on medium-term windows.
- Diversifying versus Injective with AKT can change portfolio factor exposure.
Cons of AKT
- Relative underperformance versus Injective can persist through entire market regimes.
- Smaller book depth versus large caps can increase slippage for AKT.
Which looks stronger right now?
On the latest snapshot, market-cap leadership belongs to Injective, while short-term performance leans toward AKT. That mix suggests relative strength can flip quickly, so size risk accordingly.
AI summary
PEPS synthesizes module output into a readable pair brief. Headline stats put Injective at $5.04 and AKT at $1,857.63. Relative performance over 24h (AKT) is a short window. Pair it with 30d/1y rows before inferring regime change. Return to related comparisons and individual coin intelligence pages to validate whether the relative story still holds after fresh prints.
FAQ
Which is better, Injective or AKT?
“Better” depends on horizon and risk. Injective leads on market cap today, while AKT leads the 24h move — neither is a guarantee.
Which has more upside potential, INJ or AKT?
Higher-beta assets can move more in both directions. Use performance tables and volatility, not headlines, to judge potential ranges.
Which is less risky right now?
Lower volatility and deeper liquidity usually imply milder path risk, but crypto tails remain large for both Injective and AKT.
Which has stronger developer activity?
Check the fundamentals table for developer/github fields when populated. Missing values mean the feed has no reliable reading yet.
Which looks more decentralized?
Decentralization is multi-dimensional (validators, client diversity, token distribution). This page surfaces available consensus/validator fields without over-claiming.
Which has lower fees?
Fee comparisons belong to each network’s fee market. Where gas/fee metrics exist in fundamentals, compare them; otherwise verify on explorers.
Which is better for investing?
Investing choices need personal constraints. Use this comparison as research input, then size positions with an explicit invalidation plan.
Which is better for staking?
If staking fields are present, compare yield mechanics and lockups off-platform. Staking returns are not risk-free.
Which is more used day to day?
Volume, on-chain activity and ecosystem links are practical usage proxies. AKT currently leads traded volume on this snapshot.
Which has the better recent performance?
See the performance table across 1h through 1y. The 24h leader is AKT, but longer windows can disagree.